29.12.2015 • NewsElaine BurridgeBASFSumitomo Chemical

BASF and Sumitomo Chemical Explore Alternative to Animal Testing

BASF will collaborate with Japan’s Sumitomo Chemical to research and develop an in vitro system as an alternative to animal tests for evaluating the safety of chemicals.

As a first step, the partners intend to establish a new line of fully functional cultured cells to offer a more efficient and precise procedure than existing methods.

There has been a rise in stringent regulations for registering agrochemicals and pharmaceuticals in recent years, resulting in increased demand for human safety studies.

Dr Peter Eckes, president of BASF Bioscience Research, said the collaboration combines the strength of both companies to develop new methods to reduce animal testing. Ikuzo Ogawa, managing executive officer of Sumitomo Chemical, added that his company will contribute to building a sustainable society through supplying safer chemicals.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.